Evidence map›Paper›PMID 27013804›Full record

ArticlePharmacognosy magazine2015

Inhibitory Effect of Spirulina maxima on the Azoxymethane-induced Aberrant Colon Crypts and Oxidative Damage in Mice.

Isela Álvarez-González, Víctor Islas-Islas, Germán Chamorro-Cevallos, Juan Pablo Barrios, Norma Paniagua, Verónica R Vásquez-Garzón, Saúl Villa-Treviño, Osiris-Madrigal-Santillán, José Antonio Morales-González, Eduardo Madrigal-Bujaidar

Open access · bronzeAbstract read
In one paragraph

Article in Pharmacognosy magazine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Isela Álvarez-GonzálezDepartment of Morphology, Genetics Laboratory, National School of Biological Sciences, National Polytechnic Institute, Av. Wilfredo Massieu s/n. Lindavista, D. F. 07738, México.
Víctor Islas-IslasDepartment of Morphology, Genetics Laboratory, National School of Biological Sciences, National Polytechnic Institute, Av. Wilfredo Massieu s/n. Lindavista, D. F. 07738, México.
Germán Chamorro-CevallosDepartment of Pharmacy, Preclinical Toxicology, National School of Biological Sciences, National Polytechnic Institute, Av. Wilfredo Massieu s/n. Lindavista, D. F. 07738, México.
Juan Pablo BarriosDepartment of Pharmacy, Preclinical Toxicology, National School of Biological Sciences, National Polytechnic Institute, Av. Wilfredo Massieu s/n. Lindavista, D. F. 07738, México.
Norma PaniaguaDepartment of Physiology, National School of Biological Sciences, National Polytechnic Institute, Av. Wilfredo Massieu s/n. Lindavista, D. F. 07738, México.
Verónica R Vásquez-GarzónDepartment of Cellular Biology, Center for Research and Advanced Studies, National Polytechnic Institute, Av. Instituto Politécnico Nacional 2508, San Pedro Zacatenco, D.F. 07360, México; Cathedra-CONACYT, Faculty of Medicine and Surgery, Autonomous University "Benito Juárez" of Oaxaca, Av. Universidad s/n, Exhacienda de Cinco Señores, Oaxaca de Juárez, 68120, México.
Saúl Villa-TreviñoDepartment of Cellular Biology, Center for Research and Advanced Studies, National Polytechnic Institute, Av. Instituto Politécnico Nacional 2508, San Pedro Zacatenco, D.F. 07360, México.
Osiris-Madrigal-SantillánDepartment of Conservation Medicine, Superior School of Medicine, National Polytechnic Institute, Plan de San Luis y Díaz Mirón s/n, Casco de Santo Tomás, D. F. 11340, México.
José Antonio Morales-GonzálezDepartment of Conservation Medicine, Superior School of Medicine, National Polytechnic Institute, Plan de San Luis y Díaz Mirón s/n, Casco de Santo Tomás, D. F. 11340, México.
Eduardo Madrigal-BujaidarDepartment of Morphology, Genetics Laboratory, National School of Biological Sciences, National Polytechnic Institute, Av. Wilfredo Massieu s/n. Lindavista, D. F. 07738, México.
National Polytechnic School · ECUniversidad Santo Tomás · COInstituto Politécnico Nacional · MXMorpho (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpirulina maxima (Sm) is a cyanobacterium well known because of its high nutritive value, as well as its anti-inflammatory, anti-hyperlipidemic, antioxidant, and anti-genotoxic activities.

objectiveTo determine the capacity of Sm to inhibit the induction of aberrant colon crypts (AC), as well as the level of lipid peroxidation and DNA oxidative damage in mice treated with azoxymethane (AOM). MATERIALS AND

methodsSm (100, 400, and 800 mg/kg) was daily administered to animals by the oral route during 4 weeks, while AOM (10 mg/kg) was intraperitoneally injected to mice twice in weeks 2 and 3 of the assay. We also included a control group of mice orally administered with distilled water along the assay, as well as other group orally administered with the high dose of Sm.

resultsA significant decrease in the number of AC with the three tested doses of Sm, with a mean protection of 51.6% respect to the damage induced by AOM. Also, with the three doses of the alga, we found a reduction in the level of lipoperoxidation, as well as in regard to the percentage of the DNA adduct 8-hydroxy-2'- deoxyguanosine.

conclusionSm possesses anti-precarcinogenic potential in vivo, as well as capacity to reduce the oxidative damage induced by AOM. SUMMARY: Azoxymethane (AOM) induced a high number of colon aberrant crypts in mouse. It also increased the level of peroxidation and of DNA oxidation in the same organ.Spirulina maxima significantly reduced the number of AOM-induced colon aberrant crypts in mouse. It also reduced the AOM-induced lipid and DNA oxidation in mouse.The results suggest a chemopreventive potential for the tested algae.

Indexed as

Azoxymethanechemopreventioncolon damagemiceSpirulina

Identifiers

PMID27013804
PMCPMC4787098
OpenAlexW2199992239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.